| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/23/2003 | CN1106399C Process for preparing sildenafil |
| 04/23/2003 | CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions |
| 04/23/2003 | CN1106383C Estrogenic agents |
| 04/23/2003 | CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
| 04/23/2003 | CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation |
| 04/22/2003 | US6552049 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 04/22/2003 | US6552024 For administering agents in a dissolving film configuration; drug delivery |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | US6552011 (Androst-5-en-17beta -yl)alkyl sulfoxides and sulfones and their use for control of fertility |
| 04/22/2003 | US6551626 Composition containing pyrrolizidine-alkaloid-free petasites |
| 04/22/2003 | CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031615A1 Lysophosphatidic acid synthase inhibitor |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031447A2 Pyrimidine derivatives |
| 04/17/2003 | WO2003031422A1 Novel benzothiazine derivatives, their preparation and use |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
| 04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |
| 04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
| 04/17/2003 | WO2003030895A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis |
| 04/17/2003 | WO2003030878A2 Galenic microparticulate oral formulation |
| 04/17/2003 | WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003022301A3 Use of lh in controlled ovarian hyperstimulation |
| 04/17/2003 | WO2003011293A3 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/17/2003 | WO2003005999A3 Methods of treating cytokine mediated diseases |
| 04/17/2003 | WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002076426A3 Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 04/17/2003 | WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2001076573A3 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups |
| 04/17/2003 | WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073850 Incontinence; nasal congestion |
| 04/17/2003 | US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 04/17/2003 | US20030073715 Nasal administering; side effect reduction |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073698 Nitrogen-based camptothecin derivatives |
| 04/17/2003 | US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/17/2003 | US20030073673 Hormonal contraceptive product |
| 04/17/2003 | US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030072822 Methods for treating disorders using plant extracts |
| 04/17/2003 | US20030072789 For towelette or wipes useful for feminine cleansing |
| 04/17/2003 | US20030072765 For therapy and prophylaxis of bacterial infections |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2463133A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458645A1 Intracellular signaling molecules |
| 04/17/2003 | CA2458388A1 Novel benzothiazine derivatives, their preparation and use |
| 04/16/2003 | EP1302460A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/16/2003 | EP1302203A1 Stem cell reinforcing material |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301490A2 5-substituted 2-aryl-4-pyrimidinones |
| 04/16/2003 | EP1301208A1 Vaccine |
| 04/16/2003 | EP1301200A2 Peptide pharmaceutical formulations |
| 04/16/2003 | EP1301195A2 Pharmaceutical use of fibulin-1 |
| 04/16/2003 | EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 04/16/2003 | EP1121100B1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/16/2003 | EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/16/2003 | EP1075478B1 Phenylurea and phenylthio urea derivatives |
| 04/16/2003 | EP1060187B1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/16/2003 | EP0918455B1 Use of galanin to repair nerve damage |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1410122A Chinese medicine preparation for treating acute condyloma |
| 04/16/2003 | CN1410060A 苦参碱阴道凝胶 Matrine vaginal gel |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548544 Method of treatment of priapism without raising systemic blood pressure |
| 04/15/2003 | US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms |
| 04/15/2003 | US6548498 Substituted indan derivatives |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548490 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | CA2130516C New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances |